Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

Having raised more than $1 million toward cancer research over the past nine years, the tournament is on the road to raising ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

The 63-year-old musician revealed his stage 4 prostate cancer diagnosis in November 2022, saying his cancer was “asymptomatic” after he was initially diagnosed in 2018.

At the forefront of advanced and holistic treatments, Mount Elizabeth Hospital uses a comprehensive team approach in treatments.

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Darolutamide may offer greater benefits than enzalutamide or apalutamide for Black and White patients with non-metastatic ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...